On Invalid Date, Amedisys (NASDAQ: AMED) reported Q4 2022 earnings per share (EPS) of $0.98, up 6.67% year over year. Total Amedisys earnings for the quarter were $31.72 million. In the same quarter last year, Amedisys's earnings per share (EPS) was $1.05.
As of Q1 2023, Amedisys's earnings has grown -43.06% year over year. This is 31.9 percentage points lower than the US Medical Care Facilities industry earnings growth rate of -11.16%. Amedisys's earnings in the past year totalled $118.61 million.
What is AMED's earnings date?
Amedisys's earnings date is Invalid Date. Add AMED to your watchlist to be reminded of AMED's next earnings announcement.
What was AMED's revenue last quarter?
On Invalid Date, Amedisys (NASDAQ: AMED) reported Q4 2022 revenue of $562.06 million up 0.49% year over year. In the same quarter last year, Amedisys's revenue was $559.32 million.
What was AMED's revenue growth in the past year?
As of Q1 2023, Amedisys's revenue has grown 0.41% year over year. This is 10.76 percentage points lower than the US Medical Care Facilities industry revenue growth rate of 11.17%. Amedisys's revenue in the past year totalled $2.22 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.